+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Advanced digoxin toxicity in renal failure: treatment with charcoal hemoperfusion



Advanced digoxin toxicity in renal failure: treatment with charcoal hemoperfusion



Southern Medical Journal 72(3): 279-281



Glycoside toxicity, a common and potentially fatal complication among patients taking digoxin, is treated basically by managing cardiac arrythmias until the patient can excrete enough drug to decrease the intoxication. Patients with renal failure, however, are particularly difficult to manage. We describe a case of advanced digoxin toxicity in an elderly man with severe renal failure, treated with a charcoal hemoperfusion device.

(PDF emailed within 1 workday: $29.90)

Accession: 039195435

Download citation: RISBibTeXText

PMID: 424817


Related references

Digoxin toxicity in chronic renal failure: treatment by multiple dose activated charcoal intestinal dialysis. Human & Experimental Toxicology 16(12): 733-735, 1998

Microencapsulated charcoal hemoperfusion: a possible therapeutic adjunct in digoxin toxicity. Journal of Dialysis 1(4): 367-377, 1977

Clinical experience of hemodialysis and charcoal hemoperfusion in treatment of patients with hemorrhagic fever with renal failure. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 129A, Sept, 1997

Combination treatment with digoxin antibodies and plasmapheresis for the management of digoxin toxicity in a patient with renal failure. Farmacia Hospitalaria 37(2): 170-172, 2014

Charcoal hemoperfusion for chronic renal failure. Nephron 22(4-6): 386-390, 1978

Chlorpropamide overdose in renal failure: management with charcoal hemoperfusion. American Journal of Kidney Diseases 10(6): 457-460, 1987

Charcoal hemoperfusion in a child with vancomycin overdose and chronic renal failure. Pediatric Nephrology. 12(1): 63-64,., 1998

Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin. Artificial Organs 3(2): 124-126, 1979

Charcoal hemoperfusion treatment of severe theophylline toxicity. Australian and New Zealand Journal of Medicine 15(1): 75-77, 1985

Direct hemoperfusion charcoal hemoperfusion for liver failure after operation. Artificial Organs 9(3): 313-314, 1985

Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure. Pediatric Hematology and Oncology 26(7): 520-525, 2010

Treatment of ibuprofen toxicity with serial charcoal hemoperfusion and hemodialysis in a dog. Journal of Veterinary Emergency and Critical Care 26(6): 787-792, 2016

Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. Transactions - American Society for Artificial Internal Organs 24: 243-245, 1978

Digoxin and digitoxin elimination in man by charcoal hemoperfusion. Klinische Wochenschrift 56(23): 1179-1183, 1978

Hemoperfusion hemodialysis treatment for digoxin toxicity in a uremic patient. Current Therapeutic Research 43(1): 27-31, 1988